Study Details
Full Title
Major Bleeding Risk with Concurrent Bruton Tyrosine Kinase (BTK) Inhibitors and Direct Oral Anticoagulants (DOACs) in Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): A Retrospective Multicenter Cohort Study
Principal Investigator
Danielle
Brander
Protocol Number
PRO00120335
Enrollment Status
Open to Enrollment